Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD)

CUSIP: 00534A102

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
-798,830
Put/Call ratio
53%
SEC-reported price per share
$4.56
Number of holders
70
Value change
-$29,735,160
Number of buys
46
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
296,014,274

Security key

00534A102

Report period

Q1 2022

Institutions

70

Top holders

10

Ownership snapshot

Top reported holders of IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F 3/4/5 Lead comparable stake: 5.3% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 5.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 5.3%
Alphabet Inc. 1.9%
M28 Capital Management LP 1.9%
RA CAPITAL MANAGEMENT, L.P. 1.7%
ORBIMED ADVISORS LLC 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
5.3%
$109,584,000
15,592,582 shares
31 Dec 2021
Alphabet Inc.
13F
Company
13F
1.9%
$41,242,000
5,680,785 shares
31 Dec 2021
M28 Capital Management LP
13F
Company
13F
1.9%
$41,130,000
5,665,221 shares
31 Dec 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
1.7%
$36,270,000
4,995,807 shares
31 Dec 2021
ORBIMED ADVISORS LLC
13F
Company
13F
1.7%
$36,180,000
4,983,500 shares
31 Dec 2021
Slate Path Capital LP
13F
Company
13F
1.3%
$27,116,000
3,735,000 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
70
Shares
59,134,503
Rows available
70
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
70
Q1 2022 holders
70
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .